Nexa's pyrolytic thumb implant:
This article was originally published in Clinica
Nexa Orthopedics has received US FDA 510(k) clearance to sell its pyrolytic carbon carpometacarpal implant (CMI) for relieving basal thumb joint pain associated with arthritis, while improving the thumb's range of motion and biomechanical function. The San Diego, California firm added the product to its portfolio following its recent acquisition of BioProfile, which according to Nexa, has been marketing products in Europe for "many years". Nexa claims to be the only company in the world that designs, manufactures and distributes orthopaedic implants made of pyrolytic carbon. The CMI's official US launch is scheduled to take place in September 2006 at the American Society for Surgery of the Hand meeting, in Washington, DC.